The FDA approved the use of rimegepant (Nurtec ODT [orally disintegrating tablets], Biohaven Pharmaceuticals)—an oral medication already approved for the treatment of acute migraine—to now be used for migraine prevention.
MAY 28, 2021
MAY 28, 2021
The FDA approved the use of rimegepant (Nurtec ODT [orally disintegrating tablets], Biohaven Pharmaceuticals)—an oral medication already approved for the treatment of acute migraine—to now be used for migraine prevention.